Characterization ofBCR/ABLtg/−p53+/− leukemic mice
Mouse No. . | Sex/ Age at Diagnosis, mo . | Macroscopic Tumor Sites . | Surface Markers . | DNA Status (TCR probe) . | p210bcr/abl Expression . | p53 Gene Status . |
---|---|---|---|---|---|---|
1 | F/8.0 | Thymus, PE, Spleen | Thy1.2+, CD4−, CD8− | G/R | Yes | G/T |
2 | M/2.8 | Thymus, PE | Thy1.2+, CD4+, CD8+ | G/R | Yes | Loss/T |
3 | F/11.5 | Thymus, PE, Spleen | ND | ND | Yes | G/T |
4 | M/9.7 | Thymus, PE | Thy1.2+, CD4+, CD8+ | G/R | Yes | G/T |
5 | F/3.0 | Thymus | Thy1.2+, CD4+, CD8+ | G/R | Yes | Loss/T |
6 | F/3.2 | Thymus | Thy1.2+, CD4+, CD8+ | G/R | Yes | Loss/T |
7 | M/4.0 | Thymus | Thy1.2+, CD4−, CD8+ | G/R | Yes | Loss/T |
8 | M/2.3 | Thymus, PE | Thy1.2+, CD4+, CD8− | G/R | Yes | Loss/T |
9 | M/4.1 | Thymus | ND | ND | Yes | Loss/T |
Mouse No. . | Sex/ Age at Diagnosis, mo . | Macroscopic Tumor Sites . | Surface Markers . | DNA Status (TCR probe) . | p210bcr/abl Expression . | p53 Gene Status . |
---|---|---|---|---|---|---|
1 | F/8.0 | Thymus, PE, Spleen | Thy1.2+, CD4−, CD8− | G/R | Yes | G/T |
2 | M/2.8 | Thymus, PE | Thy1.2+, CD4+, CD8+ | G/R | Yes | Loss/T |
3 | F/11.5 | Thymus, PE, Spleen | ND | ND | Yes | G/T |
4 | M/9.7 | Thymus, PE | Thy1.2+, CD4+, CD8+ | G/R | Yes | G/T |
5 | F/3.0 | Thymus | Thy1.2+, CD4+, CD8+ | G/R | Yes | Loss/T |
6 | F/3.2 | Thymus | Thy1.2+, CD4+, CD8+ | G/R | Yes | Loss/T |
7 | M/4.0 | Thymus | Thy1.2+, CD4−, CD8+ | G/R | Yes | Loss/T |
8 | M/2.3 | Thymus, PE | Thy1.2+, CD4+, CD8− | G/R | Yes | Loss/T |
9 | M/4.1 | Thymus | ND | ND | Yes | Loss/T |
PE indicates pleural effusion; G/R, germline/rearranged; G/T, germline/targeted; and ND, not done.